Potent growth inhibitory activity of zidovudine on cultured human breast cancer cells and rat mammary tumors

Cancer Research

Volumn 57, Issue 12, 1997, Pages 2341-2345

  Wagner, Carston R ^a,b,d   Ballato, George ^b   Akanni, Abraham O ^a   McIntee, Edward J ^a   Larson, Richard S ^c   Chang, Shu Ling ^a,b   Abul Hajj, Yusuf J ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Univ of New Mexico Cancer Center ^*  (United States)

^c UNIVERSITY OF NEW MEXICO   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; METHOTREXATE; METHYLNITROSOUREA; PHYTOHEMAGGLUTININ; RNA DIRECTED DNA POLYMERASE; ZIDOVUDINE; ZIDOVUDINE 5' PHOSPHATE; ZIDOVUDINE 5' TRIPHOSPHATE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; BREAST TUMOR; CANCER INHIBITION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENCY; FEMALE; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; LEUKEMIA CELL LINE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; RAT; T CELL LEUKEMIA;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; BREAST NEOPLASMS; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLOXURIDINE; HUMANS; LEUKEMIA, T-CELL; MAMMARY NEOPLASMS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; RATS; RATS, SPRAGUE-DAWLEY; RNA-DIRECTED DNA POLYMERASE; TUMOR CELLS, CULTURED; ZIDOVUDINE;

EID: 0030943965     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Sharma, M., Jain, R., Ionescu, E., and Darnowski, J. W. Quantitative analysis of 3′-azido-3′-deoxythymidine incorporation into DNA in human colon tumor cells. Bioconj. Chem., 6: 536-540, 1995.
2. Tornevik, Y., Ullman, B., Balzarini, J., Wahren, B., and Eriksson, S. Cytotoxicity of 3′-azido-3′-deoxythymidine correlates with 3′-azidothymidine-5′-monophosphate (AZTMP) levels, whereas anti-human immunodeficiency virus (HIV) activity correlates with 3′-azidothymidine-5′-triphosphate (AZTTP) levels in cultured CEM T-lymphoblastoid cells. Biochem. Pharmacol., 49: 829-837, 1995.
3. Horowitz, J. P., Chua, J., and Noel, M. J. The monomesylates of 1-(2-deoxy-β-d-lyxofuranosyl) thymines. Org. Chem. Ser. Monogr., 29: 2076-2078, 1964.
4. Hirsh, M. S. Azidothymidine. J. Infect. Dis., 157: 427-431, 1988.
5. Darnowski, J. W., and Goulette, F. A. 3′-Azido-3′-deoxythymidine cytotoxicity and metabolism in the human colon tumor cell line HCT-8. Biochem. Pharmacol., 48: 1797-1805, 1994.
6. Klann, R. C., Holbrook, C. T., and Nyce, J. W. Chemotherapy of murine colorectal carcinoma with cisplatin and cisplatin plus 3′-deoxy-3′-azidothymidine. Anticancer Res., 12: 781-787, 1992.
7. Brunetti, I., Falcone, A., Calabresi, P., Goulette, F. A., and Darnowski, J. W. 5-Fluorouracil enhances azidothymidine cytotoxicity: in vitro, in vivo, and biochemical studies. Cancer Res., 50: 4026-4031, 1990.
8. Doroshow, J. H., Newman, E., Carroll, M., Ahn, C., Akman, S., Chow, W., Coluzzi, P., Hamasaki, V., Leong, L., Margolin, K., Morgan, R., Raschko, J., Shibata, S., Somlo, G., Tetef, M., Yen, Y., Scanlon, K., Sowers, L., and Harrison, J. Phase I trial of continuous infusion zidovudine (AZT) and cisplatin in patients with advanced cancer. Proc. Annu. Meet. Am. Soc. Clin. Oncol., 13: 146, 1994.
9. Browne, M. J., Beitz, J., Clark, J. W., Cummings, F. J., Weitberg, A., Murray, C., and Darnowski, J. W. A Phase I study of zidovudine (AZT) combined with methotrexate in patients (pts) with advanced cancer. Proc. Annu. Meet. Am. Soc. Clin. Oncol., 12: A451, 1993.
10. DeLap, R., Swain, S., Ong, D., Rosen, N., Bodurian, E., Steakley, C., Nazzaro, D., King, D., and Santore, G. A Phase I study of zidovudine (AZT), leucovorin (Lv), and fluorouracil (FU) in patients with advanced cancer. Proc. Annu. Meet. Am. Soc. Clin. Oncol., 10: A295, 1991.
11. Davidsohn, I., and Nelson, D. A. In: I. Davidsohn and J. B. Henry (eds.), Clinical Diagnosis, pp. 140-157. Philadelphia: W. B. Saunders Co., 1969.
12. Wagner, C. R., McIntee, E. J., Schinazi, R. F., and Abraham, T. W. Aromatic amino acid phosphoramidate di-and triesters of 3′-azido-3′-deoxythymidine (AZT) are non-toxic inhibitors of HIV-1 replication. Bioorg. Med. Chem. Lett., 5: 1819-1824, 1995.
13. Stretcher, B. N., Pesce, A. J., Wermeling, J. R., and Hurtubise, P. E. In vitro measurement of phosphorylated zidovudine in peripheral blood leucocytes. Ther. Drug Monit., 12: 481-489, 1990.
14. Spira, T. J., Bozeman, L. H., Holman, R. C., Warfield, D. T., Phillips, S. K., and Feorino, P. M. Micromethod for assaying reverse transcriptase of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus. J. Clin. Microbiol., 25: 97-99, 1987.
15. Sommadossi, J. P., Carlisle, R., Schinazi, R. F., and Zhou, Z. Uridine reverses the toxicity of 3′-azido-3′-deoxythymidine in normal human granulocyte-macrophage progenitor cells in vitro without impairment of antiretroviral activity. Antimicrob. Agents Chemother., 32: 997-1001, 1988.
16. Yan, J. P., Ilsley, D. D., Frohlick, C., Steet, R., Hall, E. T., Kuchta, R. D., and Melancon, P. 3′-Azidothymidine (zidovudine) inhibits glycosylation and dramatically alters glycosphingolipid synthesis in whole cells at clinically relevant concentrations. J. Biol. Chem., 270: 22836-22841, 1995.
17. Hall, E. T., Yan, J. P., Melancon, P., and Kuchta, R. D. 3′-Azido-3′-deoxythymidine potently inhibits protein glycosylation. A novel mechanism for AZT cytotoxicity. J. Biol. Chem., 269: 14355-14358, 1994.
18. Nickel, W., Austermann, S., Bialek, G., and Grosse, F. Interactions of azidothymidine triphosphate with the cellular DNA polymerases alpha, delta, and epsilon and with DNA primase. J. Biol. Chem., 267: 848-854, 1992.
19. Huang, P., Farquhar, D., and Plunkett, W. Selective action of 3′-azido-3′-deoxythymidine 5′-triphosphate on viral reverse transcriptases and human DNA polymerases. J. Biol. Chem., 265: 11914-11918, 1990.
20. Abul-Hajj, Y. J. Effect of catechol estrogens on rate mammary tumors. Cancer Res., 39: 4882-4886, 1979.
21. Ratko, T. A., Detrisac, C. J., Mehta, R. G., Kelloff, G. J., and Moon, R. C. Inhibition of rat mammary gland chemical carcinogenesis by dietary dehydroepiandrosterone or a fluorinated analogue of dehydroepiandrosterone. Cancer Res., 51: 481-486, 1991.
22. Olin, B. R. Drug Facts and Comparisons, p. 404e. St. Louis: Facts and Comparisons. Inc., 1996.
23. Hasegawa, T., Juni, K., Saneyoshi, M., and Kawaguchi, T. Intestinal absorption and first-pass elimination of 2′,3′-dideoxynucleosides following oral administration in rats. Biol. Pharm. Bull., 19: 599-603, 1996.
24. Keydar, I., Ohno, T., Nayak, R., Sweet, R., Simoni, F., Weiss, F., Karby, S., Mesa-Tejada, R., and Spiegelman, S. Properties of retrovirus-like particles produced by a human breast carcinoma cell line: immunological relationship with mouse mammary tumor virus proteins. Proc. Natl. Acad. Sci. USA, 81: 4188-4192, 1984.
25. Ono, M., Kawakami, M., and Ushikubo, H. Stimulation of expression of the human endogenous retrovirus genome by female steroid hormones in human breast cancer cell line T47D. J. Virol., 61: 2059-2062, 1987.
26. May, F. E. B., and Westley, B. R. Characterization of sequences related to the mouse mammary tumor virus that are specific to MCF-7 breast cancer cells. Cancer Res., 49: 3879-3883, 1989.
27. May, F. E. B., and Westley, B. R. Structure of a human retroviral sequence related to mouse mammary tumor virus. J. Virol., 60: 743-749, 1986.
28. Moore, D. H., Charney, J., Kramarsky, B., Lasfargues, E. Y., Sarbar, N. H., Brennan, M. J., Burrows, J. H., Sirsat, S. M., Paymaster, J. C., and Vaidya, A. B. Search for a human breast cancer virus. Nature (Lond.), 229: 611-615, 1971.
29. Vogel, A., and Chandra, P. Evidence for two forms of reverse transcriptase in human placenta of a patient with breast cancer. Purification and biochemical characterization of the enzymes. Biochem. J., 197: 553-563, 1981.
30. Mays, D. C., Dixon, K. F., Balboa, A., Pawluk, L. J., Bauer, M. R., Nawoot, S., and Gerber, N. A nonprimate animal model applicable to zidovudine pharmacokinetics in humans: inhibition of glucuronidation and renal excretion of zidovudine by probenecid in rats. J. Pharmacol. Exp. Ther., 259: 1261-1270, 1991.
31. Dudley, M. N. Clinical pharmocokinetics of nucleoside antiretroviral agents. J. Infect. Dis., 171 (Suppl. 2): S99-S112, 1995.